Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia
Trial statusRecruiting
Trial phaseEarly Phase 1
Trial typeInterventional
Biological sexFemale
Age18-70
SponsorUniversity of Missouri-Columbia
About this trial
The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.
Eligibility criteria
Qualifiers
Female assigned at birth
Pre, peri- or post-menopausal
Healthy weight (BMI ≥18 and ≤30 kg/m2)
Disqualifiers
Male (assigned at birth)
Pregnancy, breastfeeding
Use of hormone replacement therapies
Hysterectomy
Trial design
Treatments tested in this trial
- Placebo
- Propranolol
- Gemtesa
Treatment groups
75 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov